| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |